Back to top

zacks-consensus-estimate: Archive

Zacks Equity Research

Why Is CrowdStrike (CRWD) Up 7% Since Last Earnings Report?

CrowdStrike (CRWD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CRWDNegative Net Change PANWNegative Net Change

Zacks Equity Research

Why Is Donaldson (DCI) Down 0.1% Since Last Earnings Report?

Donaldson (DCI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

DCINegative Net Change

Zacks Equity Research

Agilent (A) Down 2.5% Since Last Earnings Report: Can It Rebound?

Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ANegative Net Change MDTNegative Net Change

Zacks Equity Research

Abercrombie (ANF) Down 9% Since Last Earnings Report: Can It Rebound?

Abercrombie (ANF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ANFNegative Net Change TPRNegative Net Change

Zacks Equity Research

Lifecore Biomedical (LFCR) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Lifecore Biomedical (LFCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LFCRNegative Net Change

Zacks Equity Research

Why Walmart (WMT) is a Top Stock for the Long-Term

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

WMTPositive Net Change

Zacks Equity Research

Costco (COST) Surpasses Q4 Earnings Estimates

Costco (COST) delivered earnings and revenue surprises of +1.03% and -0.03%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?

COSTNegative Net Change BBBYNegative Net Change

Zacks Equity Research

Concentrix Corporation (CNXC) Q3 Earnings Miss Estimates

Concentrix (CNXC) delivered earnings and revenue surprises of -3.47% and +1.02%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?

CNXCNegative Net Change HCSGNegative Net Change

Zacks Equity Research

What Makes Atlas Copco (ATLKY) a New Buy Stock

Atlas Copco (ATLKY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ATLKYNegative Net Change

Zacks Equity Research

All You Need to Know About KT Corp. (KT) Rating Upgrade to Strong Buy

KT Corp. (KT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

KTNegative Net Change

Zacks Equity Research

All You Need to Know About Quipt Home Medical (QIPT) Rating Upgrade to Buy

Quipt Home Medical (QIPT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

QIPTNegative Net Change

Zacks Equity Research

What Makes Hillman Solutions Corp. (HLMN) a New Buy Stock

Hillman Solutions Corp. (HLMN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

HLMNPositive Net Change

Zacks Equity Research

Gentex (GNTX) Upgraded to Buy: Here's What You Should Know

Gentex (GNTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

GNTXNegative Net Change

Zacks Equity Research

All You Need to Know About Trip.com (TCOM) Rating Upgrade to Strong Buy

Trip.com (TCOM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

TCOMNegative Net Change

Zacks Equity Research

All You Need to Know About Collegium Pharmaceutical (COLL) Rating Upgrade to Strong Buy

Collegium Pharmaceutical (COLL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

COLLNegative Net Change

Zacks Equity Research

CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's What You Should Know

CAMP4 Therapeutics Corporation (CAMP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CAMPNegative Net Change

Zacks Equity Research

All You Need to Know About VEON (VEON) Rating Upgrade to Strong Buy

VEON (VEON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

VEONNegative Net Change

Zacks Equity Research

Holley (HLLY) Upgraded to Buy: Here's What You Should Know

Holley (HLLY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

HLLYNegative Net Change

Zacks Equity Research

Why Is Box (BOX) Down 0.4% Since Last Earnings Report?

Box (BOX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BOXNegative Net Change ZMNegative Net Change

Zacks Equity Research

Okta (OKTA) Down 3.4% Since Last Earnings Report: Can It Rebound?

Okta (OKTA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

OKTANegative Net Change PANWNegative Net Change

Zacks Equity Research

Wall Street Analysts Think US Gold Corp (USAU) Could Surge 28.97%: Read This Before Placing a Bet

The mean of analysts' price targets for US Gold Corp (USAU) points to a 29% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

USAUPositive Net Change

Zacks Equity Research

Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

HCANegative Net Change

Zacks Equity Research

Jabil (JBL) Beats Q4 Earnings and Revenue Estimates

Jabil (JBL) delivered earnings and revenue surprises of +11.53% and +7.67%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?

JBLNegative Net Change PLXSNegative Net Change

Zacks Equity Research

CarMax (KMX) Q2 Earnings and Revenues Lag Estimates

CarMax (KMX) delivered earnings and revenue surprises of -37.86% and -6.52%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?

KMXNegative Net Change ORLYPositive Net Change

Zacks Equity Research

Accenture (ACN) Q4 Earnings and Revenues Surpass Estimates

Accenture (ACN) delivered earnings and revenue surprises of +1.68% and +1.56%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?

ACNNegative Net Change ASGNNegative Net Change